SMTL ID : 6aru.1

Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.20 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.1: 18 residues within 4Å: Chain A: D.323, S.324, L.325, S.326, N.328, T.330, N.331, V.350, D.355, T.358, T.360 Chain C: Q.13, A.120, S.121, T.122, P.208, S.209, N.210 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain C Hydrogen bonds: A:D.323, C:N.210, C:N.210, C:S.121

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.2: 5 residues within 4Å: Chain A: E.388, N.389, N.420, T.422, N.444 No protein-ligand interaction detected (PLIP)

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 2 residues within 4Å: Chain A: K.336, N.337 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:K.336 Hydrogen bonds: A:N.337 NAG.4: 2 residues within 4Å: Chain A: N.389, R.390 No protein-ligand interaction detected (PLIP) NAG.5: 2 residues within 4Å: Chain C: Q.86, N.88 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:N.88

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Christie, M. et al., Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain. To Be Published

Release Date

2018-08-29

Peptides

Epidermal growth factor receptor: A
Cetuximab mutant light chain,Uncharacterized protein: B
Cetuximab mutant heavy chain Fab fragment,Immunoglobulin gamma-1 heavy chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Epidermal growth factor receptor

Cetuximab mutant light chain,Uncharacterized protein

Cetuximab mutant heavy chain Fab fragment,Immunoglobulin gamma-1 heavy chain

Related Entries With Identical Sequence